| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2007009092A3 Method for improved accuracy of blood testing |
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins |
| 05/03/2007 | WO2007008673A3 Crystalline anhydrous cefdinir and crystalline cefdinir hydrates |
| 05/03/2007 | WO2007007943A8 Pharmaceutical composition for treating of cancer comprising pyridylpyridazine compounds or their transition metal complexes |
| 05/03/2007 | WO2007007198A3 Retinoid immunomodulating kit and composition and uses thereof |
| 05/03/2007 | WO2007006319A3 Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 05/03/2007 | WO2007003767A3 Novel chemical compounds and the uses thereof as a medicine |
| 05/03/2007 | WO2007002093A3 Ansamycin formulations and methods of use thereof |
| 05/03/2007 | WO2007001065A3 Method for the preparation of a wet granulated drug product |
| 05/03/2007 | WO2006138534A3 Stable warfarin sodium liquid formulation and method of making same |
| 05/03/2007 | WO2006138317A3 Dosage regimen for prasugrel |
| 05/03/2007 | WO2006128169A3 Inhibition of monocyte survival, differentiation, or proliferation |
| 05/03/2007 | WO2006123358A3 Stabilized atorvastatin-containing formulation |
| 05/03/2007 | WO2006123257A3 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 05/03/2007 | WO2006122011A3 Thiazole compounds and methods of use |
| 05/03/2007 | WO2006121362A3 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | WO2006109344A3 Composition to be used for the treatment of parodontal pathologies |
| 05/03/2007 | WO2006109192A8 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 05/03/2007 | WO2006108556A3 Pharmaceutical aerosol composition |
| 05/03/2007 | WO2006106432A3 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders |
| 05/03/2007 | WO2006105056A3 Insecticidal 2,4-diaminoquinazolines and related derivatives |
| 05/03/2007 | WO2006102426A3 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders |
| 05/03/2007 | WO2006101940B1 Composition comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| 05/03/2007 | WO2006094924A3 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 05/03/2007 | WO2006094124A3 Compositions and methods for treatment of autoimmune and related diseases |
| 05/03/2007 | WO2006081779A3 A pharmaceutical composition containing olanzapine as the active agent and a process for the preparation thereof |
| 05/03/2007 | WO2006081276A8 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 05/03/2007 | WO2006074359A3 Non-irritating compositions containing zinc salts |
| 05/03/2007 | WO2006074114A3 Compositions comprising o-acetylsalicyl derivatives of aminocarbohydrates and amino acids |
| 05/03/2007 | WO2006073714A3 Use of certain phenyl-naphthyl compounds that do not have significant affintiy to er alpha or beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis |
| 05/03/2007 | WO2006067792A3 Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease |
| 05/03/2007 | WO2006060505A3 Capsaicin nutritional supplement |
| 05/03/2007 | WO2006050458A3 Tadalafil crystal forms and processes for preparing them |
| 05/03/2007 | WO2006044738A3 Methods and compositions for treatment of free radical injury |
| 05/03/2007 | WO2006041939A3 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 05/03/2007 | WO2006034048A8 Therapeutic agents targeting the ncca-atp channel and methods of use thereof |
| 05/03/2007 | WO2006024770A8 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 05/03/2007 | WO2005105107A3 Hormone treatment of multiple sclerosis |
| 05/03/2007 | WO2005102409A3 A system for perfusion management |
| 05/03/2007 | WO2005094896A3 Targeted serotonin reuptake inhibitors |
| 05/03/2007 | WO2005091716A8 Annexin ii and uses thereof |
| 05/03/2007 | WO2005075418A3 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 05/03/2007 | WO2005034726A3 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 05/03/2007 | WO2005011602A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 05/03/2007 | WO2004093811A3 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damage |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070100147 Process for preparing raloxifene hydrochloride |
| 05/03/2007 | US20070100140 used to prepare eplerenone; intermediates |
| 05/03/2007 | US20070100001 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/03/2007 | US20070100000 With particular enantiomers levo-amphetamine or levo-methamphetamine without adverse side effects; brain injuries |
| 05/03/2007 | US20070099999 Methods of treating depression |
| 05/03/2007 | US20070099998 Processes for preparing cinacalcet hydrochloride crystal form I |
| 05/03/2007 | US20070099997 Potassium or sodium salt of (-)-2-{'2-(4-hydroxyphenyl) ethyl!-thio-3-'4-(2-{4-'(methylsulfonyl) oxy! phenoxy}ethyl) phenyl! propanoic acid and their use in medicine |
| 05/03/2007 | US20070099996 Pharmaceutical compositions of acitretin |
| 05/03/2007 | US20070099995 Use of hydroxyoleic acid and related compounds as functional food additives |
| 05/03/2007 | US20070099994 Rosuvastatin calcium with a low salt content |
| 05/03/2007 | US20070099993 Antimicrobial and anticancer properties of methyl-beta-orcinolcarboxylate from lichen (Everniastrum cirrhatum) |
| 05/03/2007 | US20070099992 Direct application of vitamin C to the lung tissue and respiratory passages by use of an asthma medication-type inhaler or similar inhaler |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
| 05/03/2007 | US20070099989 Dronabinol treatment for migraines |
| 05/03/2007 | US20070099988 Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids |
| 05/03/2007 | US20070099987 Treating or preventing diabetes with cannabidiol |
| 05/03/2007 | US20070099986 Preventives/remedies for urinary disturbance |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099984 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 05/03/2007 | US20070099983 Aminocyclohexyl ether compounds and uses thereof |
| 05/03/2007 | US20070099982 Use of chp as an inhibitor of glutathione s-transferases and collagen IV |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099979 New pyrazole derivatives and diabetic medicine containing them |
| 05/03/2007 | US20070099978 Process for the preparation of 1,5 - carboxylic acid derivatives |
| 05/03/2007 | US20070099977 Conjugated psychotropic drugs and uses thereof |
| 05/03/2007 | US20070099976 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections |
| 05/03/2007 | US20070099975 Imidazole derivatives modulating the sodium channels |
| 05/03/2007 | US20070099974 (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
| 05/03/2007 | US20070099973 Process for preparation of Irbesartan |
| 05/03/2007 | US20070099972 Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate |
| 05/03/2007 | US20070099971 (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol; does not involve microtubule stabilization; Alzheimer's |
| 05/03/2007 | US20070099970 Immunomodulatory compounds that target and inhibit the pY'binding site of tyrosene kinase p56 LCK SH2 domain |
| 05/03/2007 | US20070099969 Design and synthesis of optimized ligands for ppar |
| 05/03/2007 | US20070099968 Antiviral compounds and methods |
| 05/03/2007 | US20070099967 causing nucleation in mixture with solvent between about 60 degrees C. and 100 degrees C., supersaturated; and isolating Crystalline Form 1 |
| 05/03/2007 | US20070099966 Device and Method for Inhibiting AGE Complex Formation |
| 05/03/2007 | US20070099965 2-Pyridinylethylbenzamide derivatives |
| 05/03/2007 | US20070099964 1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease |
| 05/03/2007 | US20070099962 5,6-Dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 05/03/2007 | US20070099961 Method for producing bactericidal pyridine compound and bactericidal pyridine compound |
| 05/03/2007 | US20070099960 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 05/03/2007 | US20070099959 O-Aminophenol derivatives and colorants containing these compounds |
| 05/03/2007 | US20070099958 Protease inhibitors |
| 05/03/2007 | US20070099957 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 05/03/2007 | US20070099956 Nitrogen-containing heterocyclic derivatives having 2, 6-disubstituted styryl |
| 05/03/2007 | US20070099955 3-piperidinylisochroman-5-ols as dopamine agonists |
| 05/03/2007 | US20070099954 Prodrugs of compounds that inhibit TRPV1 receptor |
| 05/03/2007 | US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 05/03/2007 | US20070099952 Hif-1 inhibitors |
| 05/03/2007 | US20070099951 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same |